Stanford University researchers have discovered why some people with attention deficit hyperactivity disorder may do well on ...

Hundreds of thousands of Australians who use a certain type of ADHD medication will be forced to use amphetamine-based ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Medications for attention-deficit/hyperactivity disorder (ADHD) have some side effects that are common, while others are more ...

Methylphenidate (Ritalin, MPH) is a psychostimulant drug approved for treatment of attention-deficit hyperactivity disorder, postural orthostatic tachycardia syndrome and narcolepsy.It may also be ...

The combined use of selective serotonin reuptake inhibitors and methylphenidate did not significantly increase adverse event risk among adults with ADHD and comorbid depression, according to a ...

Methylphenidate was associated with a small increased risk for cardiovascular events in individuals taking the drug for more than 6 months in a new cohort study. The retrospective, population ...

Methylphenidate has a possibility to interact with more drugs. These interactions are harmful. Drug interactions can be prevented by avoiding unwanted drug combinations.

This has been methylphenidate versus placebo for treating fatigue in people with advanced cancer, randomized, double-blind, multicenter, placebo-controlled clinical trial. And again, this is a dual ...

D’Aiello B, Gessi L, Menghini D, Vicari S, De Rossi P. Sleep disturbances in children with ADHD on methylphenidate monotherapy: the role of dysregulation profile. Sleep Med . 2025:128:153-158 ...